Identification of multiple sites suitable for insertion of foreign genes in herpes simplex virus genomes

Microbiology and Immunology

Volumn 53, Issue 3, 2009, Pages 155-161

  Morimoto, Tomomi ^a   Arii, Jun ^a,b   Akashi, Hiroomi ^b   Kawaguchi, Yasushi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Herpes simplex virus; Intergenic region; Multiple insertion sites

Indexed keywords

SPACER DNA; UL3 PROTEIN, HUMAN HERPESVIRUS 1; UL4 PROTEIN, HUMAN CYTOMEGALOVIRUS; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INSERTION; GENOME; GENOTYPE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; MOUSE; NONHUMAN; VIROGENESIS; VIRUS IDENTIFICATION; VIRUS VIRULENCE; ANIMAL; CELL LINE; CERCOPITHECUS; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HERPES SIMPLEX; METHODOLOGY; MOLECULAR BIOLOGY; PATHOGENICITY; RABBIT; VIROLOGY; VIRUS CULTURE;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; MUS; SIMPLEXVIRUS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DNA, INTERGENIC; FEMALE; GENETIC ENGINEERING; GENETIC VECTORS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; MICE; MOLECULAR BIOLOGY; MUTAGENESIS, INSERTIONAL; PLAQUE ASSAY; RABBITS; RECOMBINATION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 65549103925     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00104.x     Document Type: Article

References (25)

1. Aghi M., Martuza R.L. (2005) Oncolytic viral therapies - the clinical experience. Oncogene 24: 7802-16.
2. Parato K.A., Senger D, Forsyth P.A., Bell J.C. (2005) Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer 5: 965-76.
3. Murphy C.G., Lucas W.T., Means R.E., Czajak S, Hale C.L., Lifson J.D. et al. (2000) Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol 74: 7745-54.
4. Parker J.N., Gillespie G.Y., Love C.E., Randall S,Whitley R.J., Markert J.M. (2000) Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci USA 97: 2208-13.
5. Cocchi F., Menotti L., Mirandola P., Lopez M., Campadelli-Fiume G. (1998) The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J Virol 72: 9992-10002.
6. Menotti L., Casadio R., Bertucci C., Lopez M., Campadelli-Fiume G. (2002) Substitution in the murine nectin1 receptor of a single conserved amino acid at a position distal from the herpes simplex virus gD binding site confers high-affinity binding to gD. J Virol 76: 5463-71.
7. Kawaguchi Y., Tanaka M., Yokoymama A., Matsuda G., Kato K., Kagawa H. et al. (2001) Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1. Proc Natl Acad Sci USA 98: 1877-82.
8. Tanaka M., Kagawa H., Yamanashi Y., Sata T., Kawaguchi Y. (2003) Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J Virol 77: 1382-91.
9. Tanaka M., Kodaira H., Nishiyama Y., Sata T., Kawaguchi Y. (2004) Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes. Microbes Infect 6: 485-93.
10. McGeoch D.J., Dalrymple M.A., Davison A.J., Dolan A., Frame M.C., McNab D. et al. (1988) The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 69(Pt 7): 1531-74.
11. Dolan A., Jamieson F.E., Cunningham C., Barnett B.C., McGeoch D.J. (1998) The genome sequence of herpes simplex virus type 2. J Virol 72: 2010-21.
12. Ejercito P.M., Kieff E.D., Roizman B. (1968) Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol 2: 357-64.
13. RawlsW.E., Laurel D., Melnick J.L., Glicksman J.M., Kaufman R.H. (1968) A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties. Am J Epidemiol 87: 647-55.
14. Sugimoto K., Uema M., Sagara H., Tanaka M., Sata T., Hashimoto Y. et al. (2008) Simultaneous tracking of capsid, tegument, and envelope protein localization in living cells infected with triply fluorescent herpes simplex virus 1. J Virol 82: 5198-211.
15. Kawaguchi Y., Van Sant C., Roizman B. (1997) Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol 71: 7328-36.
16. Sambrook J., Russell D.W. (2001) Site-specific mutagenesis by overlap extension. Molecular Cloning, 3rd edn. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press.
17. Kato A., Yamamoto M., Ohno T., Kodaira H., Nishiyama Y., Kawaguchi Y. (2005) Identification of proteins phosphorylated directly by the Us3 protein kinase encoded by herpes simplex virus 1. J Virol 79: 9325-31.
18. Kanamori M., Watanabe S., Honma R., Kuroda M., Imai S., Takada K. et al. (2004) Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells. J Virol 78: 3984-93.
19. Hendricks R.L., Weber P.C., Taylor J.L., Koumbis A., Tumpey T.M., Glorioso J.C. (1991) Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. J Gen Virol 72(Pt 7): 1601-10.
20. Luker G.D., Bardill J.P., Prior J.L., Pica C.M., Piwnica-Worms D., Leib D.A. (2002) Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol 76: 12149-61.
21. Satoh T., Arii J., Suenaga T., Wang J., Kogure A., Uehori J. et al. (2008) PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132: 935-44.
22. Decman V., Kinchington P.R., Harvey S.A., Hendricks R.L. (2005) Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J Virol 79: 10339-47.
23. Taylor J.M., Lin E., Susmarski N., Yoon M., Zago A., Ware C.F. et al. (2007) Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe 2: 19-28.
24. Balliet J.W., Kushnir A.S., Schaffer P.A. (2007) Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice. Virology 361: 372-83.
25. Gu H., Roizman B. (2007) Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex. Proc Natl Acad Sci USA 104: 17134-9.